Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Department of Medical Laboratory Sciences, College of Medicine, University of Malawi, Blantyre, Malawi.
J Infect Dis. 2022 Jun 15;225(12):2127-2136. doi: 10.1093/infdis/jiaa616.
Rotavirus vaccine (Rotarix [RV1]) has reduced diarrhea-associated hospitalizations and deaths in Malawi. We examined the trends in circulating rotavirus genotypes in Malawi over a 22-year period to assess the impact of RV1 introduction on strain distribution.
Data on rotavirus-positive stool specimens among children aged <5 years hospitalized with diarrhea in Blantyre, Malawi before (July 1997-October 2012, n = 1765) and after (November 2012-October 2019, n = 934) RV1 introduction were analyzed. Rotavirus G and P genotypes were assigned using reverse-transcription polymerase chain reaction.
A rich rotavirus strain diversity circulated throughout the 22-year period; Shannon (H') and Simpson diversity (D') indices did not differ between the pre- and postvaccine periods (H' P < .149; D' P < .287). Overall, G1 (n = 268/924 [28.7%]), G2 (n = 308/924 [33.0%]), G3 (n = 72/924 [7.7%]), and G12 (n = 109/924 [11.8%]) were the most prevalent genotypes identified following RV1 introduction. The prevalence of G1P[8] and G2P[4] genotypes declined each successive year following RV1 introduction, and were not detected after 2018. Genotype G3 reemerged and became the predominant genotype from 2017 onward. No evidence of genotype selection was observed 7 years post-RV1 introduction.
Rotavirus strain diversity and genotype variation in Malawi are likely driven by natural mechanisms rather than vaccine pressure.
轮状病毒疫苗(Rotarix [RV1])已降低马拉维与腹泻相关的住院和死亡人数。我们在 22 年的时间内检查了马拉维循环轮状病毒基因型的趋势,以评估 RV1 引入对菌株分布的影响。
分析了在马拉维布兰太尔因腹泻住院的<5 岁儿童的粪便样本中轮状病毒阳性(1997 年 7 月至 2012 年 10 月,n = 1765;2012 年 11 月至 2019 年 10 月,n = 934)前后 RV1 引入的数据。使用逆转录聚合酶链反应分配轮状病毒 G 和 P 基因型。
在 22 年的时间里,丰富的轮状病毒株多样性不断循环;疫苗接种前后的 Shannon(H')和 Simpson 多样性(D')指数没有差异(H' P <.149;D' P <.287)。总体而言,G1(n = 268/924 [28.7%])、G2(n = 308/924 [33.0%])、G3(n = 72/924 [7.7%])和 G12(n = 109/924 [11.8%])是 RV1 引入后最常见的基因型。继 RV1 引入后,G1P[8]和 G2P[4]基因型的流行率逐年下降,并且在 2018 年后未被发现。基因型 G3 再次出现并成为 2017 年以来的主要基因型。在 RV1 引入后 7 年未观察到基因型选择的证据。
马拉维轮状病毒株多样性和基因型变异可能是由自然机制而不是疫苗压力驱动的。